Annual Revenue
$41.29 M
-$2.97 M-6.72%
December 31, 2023
Summary
- As of February 8, 2025, MXCT annual revenue is $41.29 million, with the most recent change of -$2.97 million (-6.72%) on December 31, 2023.
- During the last 3 years, MXCT annual revenue has risen by +$15.12 million (+57.78%).
- MXCT annual revenue is now -6.72% below its all-time high of $44.26 million, reached on December 31, 2022.
Performance
MXCT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$8.16 M
-$2.27 M-21.72%
September 30, 2024
Summary
- As of February 8, 2025, MXCT quarterly revenue is $8.16 million, with the most recent change of -$2.27 million (-21.72%) on September 30, 2024.
- Over the past year, MXCT quarterly revenue has increased by +$160.00 thousand (+2.00%).
- MXCT quarterly revenue is now -47.88% below its all-time high of $15.66 million, reached on December 31, 2023.
Performance
MXCT Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$45.60 M
+$160.00 K+0.35%
September 30, 2024
Summary
- As of February 8, 2025, MXCT TTM revenue is $45.60 million, with the most recent change of +$160.00 thousand (+0.35%) on September 30, 2024.
- Over the past year, MXCT TTM revenue has increased by +$7.55 million (+19.85%).
- MXCT TTM revenue is now at all-time high.
Performance
MXCT TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
MXCT Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -6.7% | +2.0% | +19.9% |
3 y3 years | +57.8% | -34.3% | +3.0% |
5 y5 years | +147.7% | -34.3% | +3.0% |
MXCT Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -6.7% | +21.8% | -47.9% | +2.0% | at high | +34.5% |
5 y | 5-year | -6.7% | +91.0% | -47.9% | +58.5% | at high | +785.4% |
alltime | all time | -6.7% | +716.0% | -47.9% | +58.5% | at high | +785.4% |
MaxCyte Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $8.16 M(-21.7%) | $45.60 M(+0.4%) |
Jun 2024 | - | $10.43 M(-8.0%) | $45.44 M(+3.1%) |
Mar 2024 | - | $11.34 M(-27.6%) | $44.05 M(+6.7%) |
Dec 2023 | $41.29 M(-6.7%) | $15.66 M(+95.7%) | $41.29 M(+8.5%) |
Sep 2023 | - | $8.00 M(-11.5%) | $38.05 M(-6.5%) |
Jun 2023 | - | $9.04 M(+5.4%) | $40.68 M(-1.4%) |
Mar 2023 | - | $8.58 M(-31.0%) | $41.25 M(-6.8%) |
Dec 2022 | $44.26 M(+30.6%) | $12.42 M(+16.7%) | $44.26 M(+5.4%) |
Sep 2022 | - | $10.64 M(+10.8%) | $41.99 M(+1.2%) |
Jun 2022 | - | $9.61 M(-17.1%) | $41.49 M(+6.4%) |
Mar 2022 | - | $11.59 M(+14.1%) | $38.99 M(+15.0%) |
Dec 2021 | $33.89 M | $10.15 M(+0.1%) | $33.89 M(+5.1%) |
Sep 2021 | - | $10.14 M(+42.6%) | $32.26 M(+11.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2021 | - | $7.11 M(+9.4%) | $28.88 M(+7.3%) |
Mar 2021 | - | $6.49 M(-23.7%) | $26.92 M(+31.8%) |
Dec 2020 | $26.17 M(+21.0%) | $8.51 M(+25.9%) | $20.43 M(+71.5%) |
Sep 2020 | - | $6.76 M(+31.3%) | $11.91 M(+131.3%) |
Jun 2020 | - | $5.15 M | $5.15 M |
Dec 2019 | $21.62 M(+29.7%) | - | - |
Dec 2018 | $16.67 M(+19.2%) | - | - |
Dec 2017 | $13.98 M(+14.0%) | - | - |
Dec 2016 | $12.27 M(+32.1%) | - | - |
Dec 2015 | $9.29 M(+29.7%) | - | - |
Dec 2014 | $7.16 M(+5.3%) | - | - |
Dec 2013 | $6.80 M(+34.5%) | - | - |
Dec 2012 | $5.06 M | - | - |
FAQ
- What is MaxCyte annual revenue?
- What is the all time high annual revenue for MaxCyte?
- What is MaxCyte annual revenue year-on-year change?
- What is MaxCyte quarterly revenue?
- What is the all time high quarterly revenue for MaxCyte?
- What is MaxCyte quarterly revenue year-on-year change?
- What is MaxCyte TTM revenue?
- What is the all time high TTM revenue for MaxCyte?
- What is MaxCyte TTM revenue year-on-year change?
What is MaxCyte annual revenue?
The current annual revenue of MXCT is $41.29 M
What is the all time high annual revenue for MaxCyte?
MaxCyte all-time high annual revenue is $44.26 M
What is MaxCyte annual revenue year-on-year change?
Over the past year, MXCT annual revenue has changed by -$2.97 M (-6.72%)
What is MaxCyte quarterly revenue?
The current quarterly revenue of MXCT is $8.16 M
What is the all time high quarterly revenue for MaxCyte?
MaxCyte all-time high quarterly revenue is $15.66 M
What is MaxCyte quarterly revenue year-on-year change?
Over the past year, MXCT quarterly revenue has changed by +$160.00 K (+2.00%)
What is MaxCyte TTM revenue?
The current TTM revenue of MXCT is $45.60 M
What is the all time high TTM revenue for MaxCyte?
MaxCyte all-time high TTM revenue is $45.60 M
What is MaxCyte TTM revenue year-on-year change?
Over the past year, MXCT TTM revenue has changed by +$7.55 M (+19.85%)